Company / Return on Equity (ROE)
Teleflex Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-29.0%
FY2025
5-year range
-29.0% / 15.5%
FY2021-FY2025
Trend
-1877.9%
vs FY2024
Sector context
#127 of 148
Health Care
What the data says
Teleflex reports negative total equity of -29.0% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-29.0% in FY2025 with a 5-year CAGR of -36.9%.
Declined from 8.0% to -29.0% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -39.0pp
- 5-Year Change
- -36.9pp
- 10-Year Change
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 148This company -29.0% Sector average -3.2%
▼
-817.6% below sector average
Key checks
Key Insights
- Teleflex's return on equity (roe) has declined for 4 consecutive years.
- In FY2025, return on equity (roe) decreased 1877.9% year-over-year.
- Currently 25.8pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -29.0% | -1877.9% |
| FY2024 | 1.6% | -79.7% |
| FY2023 | 8.0% | -20.2% |
| FY2022 | 10.1% | -35.1% |
| FY2021 | 15.5% | +95.8% |
| FY2020 | 7.9% | +31.6% |
| FY2019 | 6.0% | -45.9% |
| FY2018 | 11.1% | +76.9% |
| FY2017 | 6.3% | -28.5% |
| FY2016 | 8.8% | -28.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026